Given the above-described key role of IL-17A and IL-17F in the pathogenesis of CRC, it would be reasonable to assume that increased expression of Th-17 cytokines in patients with CRC might be associated with genetic polymorphisms that determine individual predisposition to the disease. The gene discussed is IL17A; the disease is colorectal carcinoma.